Navigation Links
Gene May Help Spur Obsessive-Compulsive Disorder
Date:8/22/2007

Mice with the mutation exhibited fearful, repetitive behaviors, researchers say

WEDNESDAY, Aug. 22 (HealthDay News) -- Mice with a particular gene mutation behave much like humans with obsessive-compulsive disorder (OCD), scientists report.

The rodents have a genetic flaw that prevents their brain cells from producing a protein called SAPAP3, according to a Duke University Medical Center-led study.

SAPAP3 plays an important role in the transmission of signals between brain cells.

Mice lacking this protein were afraid to move out of the corner of their cages and compulsively groomed their faces until they bled.

"The mice that could not produce this protein exhibited behaviors similar to that of humans with OCD, a compulsive action coupled with increased anxiety," team leader Guoping Feng, a Duke molecular geneticist, said in a prepared statement.

When the mice were given a replacement dose of SAPAP3 in an area of the brain called the striatum (which controls the planning and execution of movement), many of them showed improvement. The same was true when they were given drugs (selective serotonin reuptake inhibitors -- SSRIs) used to treat humans with OCD.

The study, which is published in the Aug. 23 issue of the journal Nature, may offer important clues about a possible mechanism for OCD, which affects about two percent of the world's population.

More information

The American Academy of Family Physicians has more about OCD.



-- Robert Preidt



SOURCE: Duke University, news release, Aug. 22, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Guidelines For Better Management Of Obsessive-Compulsive Disorder
2. Obsessive-Compulsive Disorder Is Familial
3. Eating disorder in Diabetic girls lead to eyesight damage.
4. Individuals with sleep related breathing disorders more prone to heart disease
5. Eating disorders are hereditary
6. Low testosterone levels lead to eating disorders
7. Eating disorder... a survey
8. Suicide risk in panic disorder
9. FDA approves new device to treat womens bleeding disorder
10. Genetic disorder related with sleep patterns
11. Control of anger disorder connected to Brain Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 1OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 2OPAXIO 28TM 29 Combined with Alimta 28R 29 Well Tolerated in Dose Ranging Study of Patients with Advanced Non Small Cell Lung Cancer 4808 3Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 1Dysport proves safe effective anti wrinkle treatment UT Southwestern plastic surgeons find 53439 2Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 1Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 2